Get the Stockscreener App
1.00
4.76%
-0.05
Connect Biopharma Holdings Ltd Adr stock is traded at $1.00, with a volume of 4,614.
It is down -4.76% in the last 24 hours and down -17.36% over the past month.
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
See More
Previous Close:
$1.05
Open:
$0.95
24h Volume:
4,614
Relative Volume:
0.16
Market Cap:
$56.91M
Revenue:
-
Net Income/Loss:
$-85.88M
P/E Ratio:
-0.6375
EPS:
-1.5686
Net Cash Flow:
$-80.96M
1W Performance:
+1.01%
1M Performance:
-17.36%
6M Performance:
-43.50%
1Y Performance:
-20.63%
1-Day Range:
$0.95
$1.05
1-Week Range:
$0.911
$1.11
52-Week Range:
$0.6777
$2.66
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Company Profile
Name
Connect Biopharma Holdings Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare CNTB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| CNTB | 0.9801 | 56.91M | 0 | -85.88M | -80.96M | -1.5686 |
| VRTX | 447.13 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 744.63 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 592.30 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 249.53 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 104.04 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-21 | Initiated | Jefferies | Buy |
| Apr-13-21 | Initiated | Piper Sandler | Overweight |
| Apr-13-21 | Initiated | SVB Leerink | Outperform |
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Latest News
Connect Biopharma shares hold at Buy after FDA meeting - Investing.com
Analyzing Stride (NYSE:LRN) & Visionary (NASDAQ:GV) - Defense World
CNTB Stock on the Rise: A Promising Investment - The InvestChronicle
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum - GlobeNewswire Inc.
Ratios in Focus: Analyzing Connect Biopharma Holdings Ltd ADR (CNTB)'s Price-to-Cash and Price-to-Free Cash ... - The Dwinnex
Connect Biopharma appoints new CEO and President By Investing.com - Investing.com
Market Watch: Connect Biopharma Holdings Ltd ADR (CNTB)'s Noteworthy Drop, Closing at 1.76 – DWinneX - The Dwinnex
Connect Biopharma shares target raised on strategic focus By Investing.com - Investing.com
Are Medical Stocks Lagging Bausch Health (BHC) This Year? - MSN
Has Connect Biopharma Holdings (CNTB) Outpaced Other Medical Stocks This Year? - Yahoo Finance UK
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 2.81% By Investing.com - Investing.com
Making it harder to "buy" China, Inc. - US-China Institute
Connect Biopharma Holdings Limited: Shareholders Board Members Managers and Company Profile | US2075231017 - Marketscreener.com
Connect Biopharma (CNTB) Stock Price, News & Analysis - MarketBeat
BioLine Rx (NASDAQ:BLRX) Stock Quotes, Forecast and News Summary - Benzinga
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Connect Biopharma Holdings Ltd Adr Stock (CNTB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):